Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP
出版年份 2019 全文链接
标题
Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP
作者
关键词
-
出版物
Cells
Volume 8, Issue 4, Pages 358
出版商
MDPI AG
发表日期
2019-04-18
DOI
10.3390/cells8040358
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway
- (2017) Chu Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
- (2017) Wei Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Personalized treatment of patients with very early hepatocellular carcinoma
- (2017) Alessandro Vitale et al. JOURNAL OF HEPATOLOGY
- Recent advances in hepatocellular carcinoma therapy
- (2017) Rinku Dutta et al. PHARMACOLOGY & THERAPEUTICS
- Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells
- (2017) Ai-Wen Zheng et al. Oncology Letters
- Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation
- (2017) Matthew L. Fisher et al. Oncotarget
- Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
- (2017) Sayan Chakraborty et al. Cell Reports
- Myricetin Selectively Induces Apoptosis on Cancerous Hepatocytes by Directly Targeting Their Mitochondria
- (2016) Enayatollah Seydi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- ACER3 supports development of acute myeloid leukemia
- (2016) Chen Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review
- (2016) Hassan M. Moukhadder et al. CANCER
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies
- (2016) Min Hwan Kim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway
- (2016) DE JIAO et al. ONCOLOGY REPORTS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma
- (2015) Heng Xiao et al. CANCER SCIENCE
- mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
- (2015) Yancun Yin et al. CELL RESEARCH
- Safety assessment and single-dose toxicokinetics of the flavouring agent myricitrin in Sprague–Dawley rats
- (2015) Robert R. Maronpot et al. Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment
- Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma
- (2015) Yan Guo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Molecular mechanisms underlying anticancer effects of myricetin
- (2015) Kasi Pandima Devi et al. LIFE SCIENCES
- Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells
- (2015) Jianfang Feng et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma
- (2015) Soumya C. Iyer et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
- (2015) E Ciamporcero et al. ONCOGENE
- YAP and TAZ: a nexus for Hippo signaling and beyond
- (2015) Carsten Gram Hansen et al. TRENDS IN CELL BIOLOGY
- Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells
- (2015) Haiying Cheng et al. Oncotarget
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
- (2014) Y. Zhao et al. CANCER RESEARCH
- Myricetin Induces Apoptosis in HepG2 Cells Through Akt/p70S6K/Bad Signaling and Mitochondrial Apoptotic Pathway
- (2013) Xiao-Hong Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- The Hippo Effector Yorkie Controls Normal Tissue Growth by Antagonizing Scalloped-Mediated Default Repression
- (2013) Laura M. Koontz et al. DEVELOPMENTAL CELL
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Selective apoptotic effects of piceatannol and myricetin in human cancer cells
- (2011) Paloma Morales et al. JOURNAL OF APPLIED TOXICOLOGY
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Myricetin Inhibits Akt Survival Signaling and Induces Bad-mediated Apoptosis in a Low Dose Ultraviolet (UV)-B-irradiated HaCaT Human Immortalized Keratinocytes
- (2010) Wanyeon KIM et al. JOURNAL OF RADIATION RESEARCH
- Myricetin directly targets JAK1 to inhibit cell transformation
- (2008) Takuma Kumamoto et al. CANCER LETTERS
- Myricetin Suppresses UVB-Induced Skin Cancer by Targeting Fyn
- (2008) S. K. Jung et al. CANCER RESEARCH
- Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise
- (2007) Naghma Khan et al. ANTIOXIDANTS & REDOX SIGNALING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More